Massey leader Harry Bear appointed to prestigious board
VCU Massey Cancer Center leader and physician-researcher Harry Bear, M.D., Ph.D., has been appointed to serve on the Board of Directors of the NSABP Foundation, Inc. The NSABP – National Surgical Adjuvant Breast and Bowel Project – Foundation is the world’s leading cooperative group for designing and conducting large-scale breast and colorectal cancer clinical trials. Supported by the National Cancer Institute (NCI) since its inception more than 50 years ago, the group has pioneered trials that have changed the way breast and bowel cancers are treated and prevented.
Massey offers microsurgical breast reconstruction
Santosh Kale, MD, plastic surgeon in the Division of Plastic and Reconstructive Surgery at VCU Medical Center and VCU Massey Cancer Center, is one of a few plastic surgeons in the Richmond area to offer microsurgical breast reconstruction. Because of the high level of skill and specialized equipment required to perform microsurgery, this form of breast reconstruction is typically only offered at specialized medical centers such as Massey.
Fenstermacher appointed chief research information officer at Massey
VCU Massey Cancer Center research member David A. Fenstermacher, Ph.D., has been appointed chief research information officer at Massey. In this role, Fenstermacher will oversee all aspects of the cancer center’s informatics activities. He will also collaborate with basic science, translational and clinical researchers at Massey to determine their needs for data management and analytic services to support the emergence of personalized health care, and work with VCU Health System IT and VCU IT to develop novel information systems to realize that vision.
The Promise of Immunotherapy
Recently, the American Association for Cancer Research partnered with Time magazine, the Mayo Clinic Cancer Center and the Cancer Research Institute for a Twitter chat on “The Promise of Immunotherapy.” VCU Massey Cancer Center oncologists and researchers, John McCarty, M.D., and Andrew Poklepovic, M.D., provided expert commentary as the moderators posed a series of questions and discussion topics.
Whole exome sequencing shows potential to improve efficacy of stem cell transplants
Stem cell transplant donors and recipients are matched using a process known as human leucocyte antigen (HLA) testing, but graft-versus-host disease (GVHD), in which the donor's immune system attacks the recipient’s body, continues to pose a significant threat to transplant patients. Now, researchers at Virginia Commonwealth University (VCU) Massey Cancer Center have sequenced the DNA of a small group of stem cell transplant recipients and their donors and discovered significant variation in their exomes that may help explain why some HLA-matched stem cell transplant recipients still suffer from GVHD.